Genetic Disruption of CTCF-mediated Protein complexes in Leukaemia Mutations in the genome-organising protein CTFC and its co-factors commonly occur in 40% of acute lymphoblastic leukaemia (ALL) patients. In the genetic screen in mice they will reveal whether disruption of CTFC-medicated complexes is a critical event in ALL and reveal new therapeutic targets.